Hereditary Transthyretin-mediated Amyloidosis
📧 Sign up to get email alerts when something new happens for Hereditary Transthyretin-mediated Amyloidosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-12Clinical Trial Update: Early Detection of Neuropathy in ATTRv
A University of Pennsylvania-sponsored clinical trial on early detection of neuropathy in hereditary transthyretin-mediated amyloidosis (ATT…
-
CLINICAL_TRIALS trial_result · 2022-12-19Clinical Trial Update: Evaluate the Safety and Tolerability, as Well as the Pharmacokinetic and Pharmacodynamic Profiles of Single and Multiple Doses of Eplontersen Administered Subcutaneously to Healthy Volunteers and Patients With Hereditary Transthyretin-Mediated Amyloidosis (hATTR ). [Phase 1, Phase 2]
Phase 1/2 trial evaluating safety, tolerability, pharmacokinetics, and pharmacodynamics of single and multiple subcutaneous doses of eplonte…
-
CLINICAL_TRIALS trial_result · 2015-08-24Clinical Trial Update: The Effect of Diflunisal on Familial Transthyretin Amyloidosis
Completed clinical trial evaluating the NSAID diflunisal for hereditary transthyretin-mediated amyloidosis (familial transthyretin amyloidos…